GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Olink Holding AB (NAS:OLK) » Definitions » Capex-to-Revenue

Olink Holding AB (Olink Holding AB) Capex-to-Revenue : 0.05 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Olink Holding AB Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Olink Holding AB's Capital Expenditure for the three months ended in Mar. 2024 was $-1.50 Mil. Its Revenue for the three months ended in Mar. 2024 was $28.75 Mil.

Hence, Olink Holding AB's Capex-to-Revenue for the three months ended in Mar. 2024 was 0.05.


Olink Holding AB Capex-to-Revenue Historical Data

The historical data trend for Olink Holding AB's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olink Holding AB Capex-to-Revenue Chart

Olink Holding AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
0.02 0.21 0.16 0.06 0.13

Olink Holding AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.14 0.14 0.12 0.05

Competitive Comparison of Olink Holding AB's Capex-to-Revenue

For the Diagnostics & Research subindustry, Olink Holding AB's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Olink Holding AB's Capex-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Olink Holding AB's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Olink Holding AB's Capex-to-Revenue falls into.



Olink Holding AB Capex-to-Revenue Calculation

Olink Holding AB's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-21.259) / 169.597
=0.13

Olink Holding AB's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-1.503) / 28.751
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Olink Holding AB  (NAS:OLK) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Olink Holding AB Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Olink Holding AB's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Olink Holding AB (Olink Holding AB) Business Description

Traded in Other Exchanges
Address
Uppsala Science Park, Uppsala, SWE, SE-75183
Olink Holding AB has a proprietary and patented Proximity Extension Assay technology, which enables researchers to use one platform for discovery to clinical trials to diagnostic applications utilizing the established infrastructure of labs and installed instrumentation. It has two segments including Kit and Services. It derives revenues from Sweden, the Americas, China, EMEA (Excluding Sweden) Japan, and other regions.